The MPN Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

An introduction to MPN: biology and treatment options

Jan 20, 2020
Share:

The MPN Hub were pleased to speak to Tiziano Barbui, Papa Giovanni XXIII Hospital, Bergamo, IT, during the 61st American Society of Hematology (ASH) meeting in Orlando, US. In this video, Tiziano Barbui provides an introduction to myeloproliferative neoplasms in relation to biology and treatment options.

Tiziano Barbui gives an in-depth overview of the biology and treatment landscape of myeloproliferative neoplasms (MPN). He discusses the types of neoplasms that constitute MPN and the identified phenotype that drives this disease. Additionally, he discusses the disease characteristics, risk factors and its evolutionary potential to cancer. Tiziano Barbui also talks about the current treatment guidelines in both the US and Europe such as the IPSET-thrombosis classification.

An introduction to MPN: biology and treatment options

Share: